Milestone Pharmaceuticals Inc.
MIST
$1.69
-$0.01-0.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.53M | -51.93M | -41.52M | -42.77M | -48.41M |
| Total Depreciation and Amortization | 647.00K | 645.00K | 646.00K | 611.00K | 610.00K |
| Total Amortization of Deferred Charges | 400.00K | 385.00K | 370.00K | 357.00K | 342.00K |
| Total Other Non-Cash Items | 7.99M | 7.90M | 8.00M | 8.42M | 9.94M |
| Change in Net Operating Assets | 6.12M | 9.13M | 3.66M | 1.58M | 578.00K |
| Cash from Operations | -40.38M | -33.87M | -28.85M | -31.80M | -36.94M |
| Capital Expenditure | -43.00K | -39.00K | -33.00K | -42.00K | -56.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.39M | 68.92M | 8.32M | 2.67M | -14.66M |
| Cash from Investing | 69.34M | 68.88M | 8.28M | 2.63M | -14.71M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 274.00K | 238.00K | 27.75M | 27.73M | 27.96M |
| Repurchase of Common Stock | -- | -251.00K | -251.00K | -251.00K | -251.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -47.00K | 4.62M | 4.62M | 4.62M |
| Cash from Financing | 274.00K | -60.00K | 32.12M | 32.10M | 32.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.24M | 34.95M | 11.55M | 2.92M | -19.33M |